iQure Pharma, a Princeton, NJ-based biotech company, raised $600K in Early Closing as part of its Series A funding.
The round was led by Keiretsu Mid-Atlantic, together with business angels associated with Keiretsu’s Accelerator Fund and the Keiretsu North-West chapter.
The company intends to use the funds for research into neuropathic pain compounds.
Led by Coo Pawel Zolnierczyk, iQure Pharma is focused on the development of therapeutics for neuropathic pain, epilepsy, and wider neurodegenerative diseases. The company aims to advance the preclinical development novel therapeutics iQ-007 and iQ-008. In particular, iQ-007 has demonstrated positive results in NIH ETSP tests, which show that the compound has the ability to treat pain, epilepsy, and potentially neurodegenerative diseases. Additionally, iQ-008 has progressed within the NIH PSPP program focused on pain. iQ-008, a novel analgesic compound, is progressing to the next stage in the Preclinical Screening Platform for Pain (PSPP), which has been set up under the HEAL initiative to facilitate the identification of potential non-addictive treatments for acute and chronic pain conditions and alternatives to opioid analgesics.
iQure Pharma Raises $600K in Early Closing of Series A. Congratulations to the entire team. I wish you great success in this endeavour.Shishir Gupta, Founder and CEO, StartupLanes
Don’t keep wondering about funding, you can also raise funds. Learn how to raise funds here: Yes I want to raise funds.
If you are an emerging startup and are looking for investors to raise funds, StartupLanes has its own angel network and investment banking services and is connected to angel investors and VCs in 15 countries that ensure that our member startups have easy access to external funds to scale up constantly.
You can subscribe to our news posts by entering your email in the box on the right side of this page.
Check out our YouTube channel for insightful content from the Indian startup ecosystem.
The right investment is key to beating inflation and growing your wealth. Do you wish to become an angel investor? Yes, I want to be an angel investor.
Are you a startup and facing challenges in your business? Do you want to grow your business? It is not as difficult as it sounds. Learn how to grow your business here- Yes, I want to grow my business. For any rectifications, reach out to firstname.lastname@example.org